CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Helsinn Healthcare S.A. v. Par Pharmaceutical Companies Inc.

1:15-cv-00265

Overview

Case Number 1:15-cv-00265
Filing Date 2015-03-25
Status Terminated
Termination Date 2015-12-03
Court District Court, D. Delaware (ded)
Presiding Judge Gregory M. Sleet
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand None

Parties

Defendant

Par Pharmaceutical Inc.

Represented By

1 Attorneys Listed

Stephen B. Brauerman

Bayard, P.A.

Tel: +1 (302) 655-5000
Fax: +1 (302) 658-6395

Bayard, P.A., 600 N. King Street

Par Pharmaceutical Companies Inc.

Represented By

1 Attorneys Listed

Stephen B. Brauerman

Bayard, P.A.

Tel: +1 (302) 655-5000
Fax: +1 (302) 658-6395

Bayard, P.A., 600 N. King Street

Plaintiff

Roche Palo Alto LLC

Represented By

2 Attorneys Listed

Maryellen Noreika

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Helsinn Healthcare S.A.

Represented By

2 Attorneys Listed

Maryellen Noreika

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Court & Judges

Court

District Court, D. Delaware (ded)

Presiding Judge

Gregory M. Sleet

Docket Entries

COMPLAINT FOR PATENT INFRINGEMENT filed against Par Pharmaceutical Companies Inc., Par Pharmaceutical Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 311-1696908.) - filed by Roche Palo Alto LLC, Helsinn Healthcare S.A.. (Attachments: # 1 Exhibit A-E, # 2 Civil Cover Sheet)(dmp, ) (Entered: 03/26/2015)

2015-03-25
1

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (dmp, ) (Entered: 03/26/2015)

2015-03-25
1

Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 02/11/2015. Date of Expiration of Patent: 01/30/2024.Thirty Month Stay Deadline: 8/11/2017. (dmp, ) (Entered: 03/26/2015)

2015-03-25
1

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,947,724 B2; 7,947,725 B2; 7,960,424 B2; 8,598,219 B2; 8,729,094 B2;. (dmp, ) (Entered: 03/26/2015)

2015-03-25
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc